Human Oncology & Pathogenesis Program
The Omar Abdel-Wahab Lab
Research

Professor
Omar Abdel-Wahab is a Member in Human Oncology and Pathogenesis Program (HOPP), an Attending Physician on the Leukemia Service in the Department of Medicine at Memorial Sloan Kettering Cancer Center, and the Director of Memorial Sloan Kettering’s Center for Hematologic Malignancies. Dr. Abdel-Wahab’s research focuses on the role of genomic alterations in the pathogenesis of hematopoietic malignancies.

Featured News



Publications
People

Omar Abdel-Wahab, MD
Edward P. Evans Chair in MDS, Director, MSK Center for Hematologic Malignancies, Member, Human Oncology and Pathogenesis Program & Leukemia Service
Professor
- Physician-scientist Omar Abdel-Wahab studies the functional genomics of hematopoietic malignancies.
- MD, Duke University School of Medicine
- abdelwao@mskcc.org
- Email Address
- View physician profile
- Physician profile
Members

Research Scholar

Research Fellow

Research Scholar

Research Assistant

Instructor (Pathology)

Research Technician

Research Technician

Research Fellow

Graduate Student

Fellow

Research Associate

Research Associate

Program Assistant
Senior Research Scientist

Research Technician

Fellow

Senior Research Assistant

Research Scholar
Lab Alumni

Volunteer

Research Fellow

Research Technician

Research Technician

Research Technician
Research Fellow

Administrative Assistant II

Visiting Investigator

Research Technician

Research Fellow

Research Technician

Research Associate

Assistant Member, Myeloma Service

Research Fellow

Senior Research Scientist

Senior Computational Biologist

Instructor (Dept. of Medicine)

Senior Research Scientist
Lab Affiliations
Achievements
- Josie Robertson Investigator (2012-2017)
- Seldin-Smith Award for Pioneering Research, American Society of Clinical Investigation
- Pershing Square Sohn Prize for Young Investigators in Cancer Research
- Leukemia & Lymphoma Society Clinical Scholar Award
- Joanne Levy Memorial Award for Outstanding Achievement, American Society of Hematology
Read more
- V Scholar Award, V Foundation
- Junior Faculty Scholar Award, American Society of Hematology (ASH)
- Damon Runyon Clinical Investigator Award
Get in Touch
-
Lab Head Email
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Omar Abdel-Wahab discloses the following relationships and financial interests:
-
AIchemy, Inc.
Ownership / Equity Interests; Provision of Services (uncompensated) -
Envisagenics
Ownership / Equity Interests; Provision of Services (uncompensated)
-
Epizyme
Intellectual Property Rights -
Janssen Global Services, LLC
Provision of Services
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.